BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8167039)

  • 21. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upper neck (level II) dissection for N0 neck supraglottic carcinoma.
    Tu GY
    Laryngoscope; 1999 Mar; 109(3):467-70. PubMed ID: 10089977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of the N0 neck in moderately advanced squamous carcinoma of the larynx.
    Dias FL; Lima RA; Manfro G; Barbosa MM; Salviano S; Rocha RM; Marques AS; Cernea CR; Kligerman J
    Otolaryngol Head Neck Surg; 2009 Jul; 141(1):59-65. PubMed ID: 19559959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
    Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
    Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nodal metastases at level IIb during neck dissection for head and neck cancer: clinical and pathologic evaluation.
    Santoro R; Franchi A; Gallo O; Burali G; de' Campora E
    Head Neck; 2008 Nov; 30(11):1483-7. PubMed ID: 18798305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Supraglottic horizontal-vertical hemilaryngectomy].
    Zhu S; Kang X; Li G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(1):13-5. PubMed ID: 8031594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distant metastases in laryngeal squamous cell carcinoma.
    Yücel OT; Yilmaz T; Unal OF; Turan E
    J Exp Clin Cancer Res; 1999 Sep; 18(3):285-8. PubMed ID: 10606170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of routine bilateral neck dissection in the management of supraglottic cancer.
    Chiu RJ; Myers EN; Johnson JT
    Otolaryngol Head Neck Surg; 2004 Oct; 131(4):485-8. PubMed ID: 15467622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognosis of laryngeal carcinoma in youth].
    Gan X; Zhou Y; Cai L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):201-2. PubMed ID: 9642341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical staging for primary malignancies of the supraglottic larynx.
    Zamora RL; Harvey JE; Sessions DG; Spitznagel EL
    Laryngoscope; 1993 Jan; 103(1 Pt 1):69-77. PubMed ID: 8421423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of selective neck dissection in pathological N1 squamous cell carcinomas of the head and neck.
    Yıldırım T; Ozmen OA; Erişen L; Kasapoğlu F; Coşkun H; Basut O; Onart S; Hızalan I
    Kulak Burun Bogaz Ihtis Derg; 2011; 21(2):63-9. PubMed ID: 21417967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Horizontal supraglottic laryngectomy. Technique, indications, oncologic results and early functional results. Apropos of 87 cases].
    Maurice N; Delol J; Makeieff M; Arnoux A; Crampette L; Guerrier B
    Ann Otolaryngol Chir Cervicofac; 1996; 113(4):203-11. PubMed ID: 9033686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of therapeutic (N1, N2) selective neck dissection (levels II to V) in patients with laryngeal and hypopharyngeal squamous cell carcinoma.
    Lohuis PJ; Klop WM; Tan IB; van Den Brekel MW; Hilgers FJ; Balm AJ
    Am J Surg; 2004 Feb; 187(2):295-9. PubMed ID: 14769324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lateral neck dissection of hypopharyngeal cancer with clinically regional metastasis].
    Wang X; Tang P; Tu G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Jun; 35(3):175-7. PubMed ID: 12768770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does unnecessary elective neck treatment affect the prognosis of N0 laryngeal cancer patients?
    Sarno A; Bocciolini C; Deganello A; Coscarelli S; Gallo O
    Acta Otolaryngol; 2004 Oct; 124(8):980-5. PubMed ID: 15513537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The surgical treatment for the epiglottic cancer extended to the base of tongue].
    Zhuang H; Liang S; Ji H
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(6):368-70. PubMed ID: 9640702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supraglottic hemipharyngolaryngectomy for the treatment of T1 and T2 carcinomas of laryngeal margin and piriform sinus.
    Makeieff M; Mercante G; Jouzdani E; Garrel R; Crampette L; Guerrier B
    Head Neck; 2004 Aug; 26(8):701-5. PubMed ID: 15287037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.